Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neck Lines”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT05798819
What this trial is testing

GLS-010 Plus Platinum-containing Chemotherapy±Bevacizumab as First-line Treatment for Persistent, Recurrent, or Metastatic Cervical Cancer

Who this might be right for
Persistent, Recurrent, or Metastatic Cervical Cancer
Guangzhou Gloria Biosciences Co., Ltd. 424
Testing effectiveness (Phase 2)Study completedNCT02605967
What this trial is testing

Safety and Efficacy Study of PDR001 in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Novartis Pharmaceuticals 122
Testing effectiveness (Phase 2)Ended earlyNCT03894215
What this trial is testing

RaPiDS- A Phase 2 Study of Anti-PD-1 Independently or in Combination With Anti-CTLA-4 in Second-Line Cervical Cancer

Who this might be right for
Cervical Cancer
Agenus Inc. 211
Not applicableStudy completedNCT05303740
What this trial is testing

Anlotinib Retrospective Study for Esophageal Cancer

Who this might be right for
Esophageal Neoplasms
Feng Wang 300
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07628855
What this trial is testing

A Prospective, Single-arm, Phase II Clinical Trial of Becotatug Vedotin for Injection Combined With Pucotenlimab Injection as a First-line Treatment for Platinum-intolerant Advanced Head and Neck Squamous Cell Carcinoma

Who this might be right for
HNPCC
Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center 30
Large-scale testing (Phase 3)UnknownNCT02677597
What this trial is testing

Cisplatin Combined With S-1 or Paclitaxel as First-line Treatment for Metastatic Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
Fudan University 268
Not applicableStudy completedNCT04162496
What this trial is testing

Restylane Refyne for Correction of Horizontal Neck Rhytides

Who this might be right for
AgingWrinkleRhytides
Siperstein Dermatology 26
Large-scale testing (Phase 3)Study completedNCT00401323
What this trial is testing

Taxotere (Docetaxel) in 1st Line Treatment of Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck NeoplasmsNeoplasm Recurrence, LocalNeoplasm Metastasis
Sanofi 568
Testing effectiveness (Phase 2)Looking for participantsNCT06494995
What this trial is testing

AK104 and Low-dose Radiation in Recurrent/Metastatic HNSCC After Failure of First-line Systemic Therapy

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Fudan University 52
Testing effectiveness (Phase 2)Looking for participantsNCT06052839
What this trial is testing

Pulsed Dose Chemotherapy Plus Pembrolizumab in Recurrent/Metastatic HNSCC

Who this might be right for
Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC)
Dan Zandberg 15
Testing effectiveness (Phase 2)UnknownNCT05189184
What this trial is testing

Study of Camrelizumab in Combination With Apatinib Mesylate Plus Albumin-bound Paclitaxel and Cisplatin as the First Line Treatment of Recurrent or Metastatic, UnresectableHead and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Squamous Cell Carcinoma
The First Affiliated Hospital of Zhengzhou University 30
Large-scale testing (Phase 3)Study completedNCT03430843
What this trial is testing

Tislelizumab (BGB-A317) Versus Chemotherapy as Second Line Treatment in Participants With Advanced Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma (ESCC)
BeiGene 512
Large-scale testing (Phase 3)Looking for participantsNCT05854849
What this trial is testing

Gemcitabine and Camrelizumab Plus Apatinib Versus Cisplatin in First-line Treatment of RM-NPC

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 244
Testing effectiveness (Phase 2)UnknownNCT05456022
What this trial is testing

Therapeutic Efficacy of Quercetin Versus Its Encapsulated Nanoparticle on Tongue Squamous Cell Carcinoma Cell Line

Who this might be right for
Oral Cancer
Cairo University 1,000,000
Testing effectiveness (Phase 2)Looking for participantsNCT06769698
What this trial is testing

See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Squamous Cell Carcinoma (HNSCC)
Regeneron Pharmaceuticals 120
Not applicableUnknownNCT04813406
What this trial is testing

Study of Anlotinib Plus Sintilimab in the Treatment of Advanced Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
Henan Provincial People's Hospital 53
Large-scale testing (Phase 3)Looking for participantsNCT06788990
What this trial is testing

FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC

Who this might be right for
Metastatic Head and Neck Squamous Cell CarcinomaRecurrent Head and Neck Squamous Cell Carcinoma
Bicara Therapeutics 650
Testing effectiveness (Phase 2)Looking for participantsNCT05260671
What this trial is testing

Penpulimab in Combination With Cetuximab as First-line Treatment in R/M SCCHN

Who this might be right for
Head and Neck NeoplasmsRecurrent DiseaseMetastatic Cancer
Eye & ENT Hospital of Fudan University 48
Not applicableStudy completedNCT07067073
What this trial is testing

ANTI-DYNAMIC LINE Test for Cream

Who this might be right for
Dynamic Wrinkles
ChinaNorm 45
Testing effectiveness (Phase 2)Study completedNCT00813072
What this trial is testing

Study of PEP02, Irinotecan or Docetaxel in Gastric or Gastroesophageal Junction Adenocarcinoma

Who this might be right for
Stomach NeoplasmsEsophageal Neoplasms
PharmaEngine 135
Next Page